Liu, K., Guan, Z., Liang, Y., Yang, X., Peng, J., Huang, H., . . . Wu, H. (2014). A double-blind, randomized phase II study of dicycloplatin plus paclitaxel versus carboplatin plus paclitaxel as first-line therapy for patients with advanced non-small-cell lung cancers. Termedia Publishing House.
Citación estilo ChicagoLiu, Ke-Jun, et al. A Double-blind, Randomized Phase II Study of Dicycloplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel As First-line Therapy for Patients With Advanced Non-small-cell Lung Cancers. Termedia Publishing House, 2014.
Cita MLALiu, Ke-Jun, et al. A Double-blind, Randomized Phase II Study of Dicycloplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel As First-line Therapy for Patients With Advanced Non-small-cell Lung Cancers. Termedia Publishing House, 2014.